Literature DB >> 27840085

Lowering the overall charge on TMPyP4 improves its selectivity for G-quadruplex DNA.

Thomas L Ruan1, Supriya J Davis1, Barrett M Powell1, Cole P Harbeck1, Jan Habdas2, Piotr Habdas3, Liliya A Yatsunyk4.   

Abstract

Ligands that stabilize non-canonical DNA structures called G-quadruplexes (GQs) might have applications in medicine as anti-cancer agents, due to the involvement of GQ DNA in a variety of cancer-related biological processes. Five derivatives of 5,10,15,20-tetrakis(N-methyl-4-pyridyl)porphyrin (TMPyP4), where a N-methylpyridyl group was replaced with phenyl (4P3), 4-aminophenyl (PN3M), 4-phenylamidoproline (PL3M), or 4-carboxyphenyl (PC3M and P2C2M) were investigated for their interactions with human telomeric DNA (Tel22) using fluorescence resonance energy transfer (FRET) assay, and UV-visible and circular dichroism spectroscopies in K+ buffer. The molecules are cationic or zwitterionic with an overall charge of 3+ (4P3, PN3M, and PL3M), 2+ (PC3M) or neutral (P2C2M). All porphyrins except P2C2M stabilize human telomeric DNA in FRET assays by ∼20 °C at 5 eq CD melting experiments suggest that 4P3 is the most stabilizing ligand with a stabilization temperature of 16.8 °C at 4 eq. Importantly, 4P3, PC3M and PL3M demonstrate excellent selectivity for quadruplexes, far superior to that of TMPyP4. Binding constants, determined using UV-vis titrations, correlate with charge: triply cationic 4P3, PN3M and PL3M display Ka of 5-9 μM-1, doubly cationic PC3M displays Ka of 1 μM-1, and neutral P2C2M displays weak-to-no binding. UV-vis data suggest that binding interactions are driven by electrostatic attractions and that the binding mode may be base-stacking (or end-stacking) judging by the high values of red shift (15-20 nm) and hypochromicity (40-50%). We conclude that lowering the charge on TMPyP4 to 3+ can achieve the desired balance between stabilizing ability, affinity, and high selectivity required for an excellent quadruplex ligand.
Copyright © 2016 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Binding constants; FRET; Guanine quadruplex; Human telomeric DNA; TMPyP4 derivatives

Mesh:

Substances:

Year:  2016        PMID: 27840085     DOI: 10.1016/j.biochi.2016.11.003

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  6 in total

1.  Potentiation by potassium iodide reveals that the anionic porphyrin TPPS4 is a surprisingly effective photosensitizer for antimicrobial photodynamic inactivation.

Authors:  Liyi Huang; Ahmed El-Hussein; Weijun Xuan; Michael R Hamblin
Journal:  J Photochem Photobiol B       Date:  2017-10-31       Impact factor: 6.252

2.  Stabilization of human telomeric RNA G-quadruplex by the water-compatible optically pure and biologically-active metallohelices.

Authors:  Jaroslav Malina; Peter Scott; Viktor Brabec
Journal:  Sci Rep       Date:  2020-09-03       Impact factor: 4.379

3.  Interactions Between Spermine-Derivatized Tentacle Porphyrins and The Human Telomeric DNA G-Quadruplex.

Authors:  Navin C Sabharwal; Jessica Chen; Joo Hyun June Lee; Chiara M A Gangemi; Alessandro D'Urso; Liliya A Yatsunyk
Journal:  Int J Mol Sci       Date:  2018-11-21       Impact factor: 5.923

4.  Design, Synthesis and Biological Evaluation of New Substituted Diquinolinyl-Pyridine Ligands as Anticancer Agents by Targeting G-Quadruplex.

Authors:  Rabindra Nath Das; Edith Chevret; Vanessa Desplat; Sandra Rubio; Jean-Louis Mergny; Jean Guillon
Journal:  Molecules       Date:  2017-12-30       Impact factor: 4.411

5.  Metalloporphyrin Pd(T4) Exhibits Oncolytic Activity and Cumulative Effects with 5-ALA Photodynamic Treatment against C918 Cells.

Authors:  Brandon Leviskas; Tibor Valyi-Nagy; Gnanasekar Munirathinam; Matthew Bork; Klara Valyi-Nagy; Troy Skwor
Journal:  Int J Mol Sci       Date:  2020-01-20       Impact factor: 5.923

Review 6.  Major Achievements in the Design of Quadruplex-Interactive Small Molecules.

Authors:  Eduarda Mendes; Israa M Aljnadi; Bárbara Bahls; Bruno L Victor; Alexandra Paulo
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.